期刊文献+

PPARδ基因过表达对RAW264.7细胞MCP-1及VCAM-1表达的影响

PPAR gene transfection inhibits oxidized low-density lipoprotein-induced MCP-1 and VCAM-1 gene and protein expression in RAW264.7 cells
下载PDF
导出
摘要 目的:观察过氧化物酶增殖体激活受体δ(PPARδ)基因转染对氧化型低密度脂蛋白(ox-LDL)诱导的鼠源性单核细胞RAW264.7中单核细胞趋化蛋白-1(MCP-1)及血管细胞间黏附分子-1(VCAM-1)基因和蛋白表达的影响。方法:构建表达人PPARδ基因的复制缺陷型腺病毒表达载体(Ad-PPARδ),并培养RAW264.7细胞。实验分为未转染的对照组、PPARδ基因转染组及假转染组。将RAW264.7细胞与ox-LDL(50 mg/L)孵育24 h后,采用RT-PCR及蛋白免疫印迹法分别检测各组细胞MCP-1及VCAM-1 mRNA及其蛋白的表达。采用单核细胞趋化试验检测人外周血单核细胞在不同条件培养基中的趋化活性。结果:PPARδ基因转染组细胞中MCP-1及VCAM-1的表达明显低于对照组及假转染组(P<0.05);单核细胞移动的距离明显小于对照组及假转染组(P<0.05)。假转染组与对照组比较,MCP-1及VCAM-1的表达及单核细胞移动的距离无显著差异。结论:PPARδ基因转染能抑制ox-LDL诱导的MCP-1及VCAM-1表达,增加PPARδ的表达可能具有防治动脉粥样硬化的作用。 AIM: To investigate whether peroxisome proliferator-activated receptor δ(PPAR8) gene transfection inhibits oxidized low-density lipoprotein (ox-LDL)-induced monocyte chemoattractant pro- rein-1 (MCP-1) and vascular cell adhesion molecule-1 (VCAM-1) gene and protein expression in RAW264. 7 cells. METHODS: A replication-deficient recombinant adenovirus expression vector of human PPARδ was constructed using the AdEasy system. RAW264. 7 cells were randomly divided into three groups: control group, P group (PPARδ gene transfection group) and ST group (sham transfected group). RAW264.7 cells were incubated for 24 h with ox-LDL (50 rag/L). Changes of MCP-I and VCAM-1 at mRNA and protein levels in different groups were detected by RT-PCR and immunoblotting. Conditioned media with or without PPARδ gene transfection were collected for chemotaxis assay by micro- pore filter using a modified Boyden chamber. RESULTS: MCP-1 and VCAM-1 mRNA as well as protein expressions from P group were significantly lower than in control group and ST group ( P 〈 0. 01 ). Compared with control group and ST group, monocyte chemotactic activity was noticeably inhibited in P group (P 〈 0. 05). No significant difference was observed between control group and ST group. CONCLUSION: PPAR~ gene transfection inhibits ox-LDL-induced MCP-1 and VCAM-1 expression. Activation of PPARδ may play an important role in the prevention of atherosclerosis.
出处 《心脏杂志》 CAS 2011年第3期313-317,321,共6页 Chinese Heart Journal
关键词 动脉粥样硬化 巨噬细胞 过氧化酶物增殖体激活受体δ 炎症介质 Key words: atherosclerosis macrophage peroxisome proliferator-activated receptor δ inflammatory mediators
  • 相关文献

参考文献18

  • 1Ross R.Atherosclerosis--an inflammatory disease[J].N Engl J Med,1999,340(2):115-126.
  • 2Tulenko TN,Sumner AE.The physiology of lipoproteins[J].J Nucl Cardiol,2002,9(6):638-649.
  • 3Frostegard J,Ulfgren AK,Nyberg P,et al.Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory(Th1)and macrophage-stimulating cytokines[J]. Atherosclerosis,1999,145(1):33-43.
  • 4Takata Y,Liu J,Yin F,et al.PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis[J].Proc Natl Acad Sci U S A,2008,105(11):4277-4282.
  • 5Barish GD,Atkins AR,Downes M,et al.PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis[J].Proc Natl Acad Sci U S A.2008.105(11):4271-4276.
  • 6Chinetti G,Fruchart JC,Staels B.Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation[J].Inflamm Res,2000,49(10):497-505.
  • 7Yan ZC, Liu DY,Zhang LL,et al.Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta[J].Biochem Biophys Res Commun,2007,354(2):427-433.
  • 8Zawadzki Z, Milne RW,Marcel YL.Cu2(+)-mediated oxidation of dialyzed plasma:effects on low and high density lipoproteins and cholesteryl ester transfer protein[J].J Lipid Res,1991,32(2):243-250.
  • 9程向缨,王拥军,温玫,于凯,杨静芳,董秀敏,武剑.中药总蒽醌粗提物对低密度脂蛋白氧化的抑制作用[J].中国老年学杂志,2000,20(5):299-301. 被引量:7
  • 10赵霞,祝学卫,杨丽敏,邓仲端,朱大和.脂质过氧化诱导培养的内皮细胞产生单核细胞趋化因子RANTES[J].中国动脉硬化杂志,2001,9(4):281-284. 被引量:7

二级参考文献16

  • 1洪伟,陈铁镇.内皮细胞脂质过氧化损伤与单核细胞内皮下穿入──利用血管内膜培养模型的研究[J].中国医科大学学报,1994,23(3):189-193. 被引量:3
  • 2丁林生.中药化学[M].北京:中国中医药出版社,1997.105.
  • 3丁林生,中药化学,1997年,59页
  • 4Steinbrecher UP,Parthasarathy S,Leake DS,et al.Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids[J].PNAS,1984,81 (12):3883-3887.
  • 5Itabe H,Takeshima E,Iwasaki H,et al.A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions.Complex formation of oxidized phosphatidylcholines and polypeptides[J].J Biol Chem,1994,269(21):15274-15279.
  • 6Itabe H,Yamamoto H,Imanaka T,et al.Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody[J].JLipid Res,1996,37(1):45 -53.
  • 7Kotani K,Maekawa M,Kanno T,et al.Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum[J].Biochim Biophys Acta,1994,1215(1 -2):121-125.
  • 8Holvoet P,Perez G,Zhao Z,et al.Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease[J].J Clin Invest,1995,95 (6):2611-2619.
  • 9Holvoet P,Vanhaecke J,Janssens S,et al.Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease[J].Circulation,1998,98(15):1487-1494.
  • 10Ehara S,Ueda M,Naruko T,et al.Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes[J].Circulation,2001,103 (15):1955 -1960.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部